Abstract Details

Title Safety Profile of Repeat OnabotulinumtoxinA Doses of 400U for the Treatment of Upper Limb Spasticity

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 334

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Lynn M. James (Allergan Plc) PRESENTER	Ms. James has received personal compensation for serving as an employee of AbbVie. Ms. James has stock in AbbVie.
Rozalina Dimitrova, MD, MPH (Allergan, Inc)	No disclosure on file
	No disclosure on file
	No disclosure on file
Lana Zhovtis Ryerson, MD, FAAN (Jersey Shore University Medical Center)	Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Catherine Thompson	No disclosure on file

��ɫ����